TRCT
EXOZ

Tower Research Capital (TRC)’s eXoZymes Inc EXOZ Stock Holding History

Tower Research Capital (TRC)’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.89K Buy
1,317
+1,315
+65,750% +$12K ﹤0.01% 3908
2025
Q4 		$22 Buy
+2
New +$28 ﹤0.01% 5098
2025
Q3 		– Sell
-344
Closed -$3.4K – 5744
2025
Q2 		$3.4K Sell
344
-789
-70% -$9.62K ﹤0.01% 4500
2025
Q1 		$11.8K Buy
1,133
+744
+191% +$11.1K ﹤0.01% 3497
2024
Q4 		$6.42K Buy
+389
New +$5.74K ﹤0.01% 4172

Other funds holding EXOZ

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s EXOZ Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its eXoZymes Inc (EXOZ) stake by 65,750% in Q1 2026, buying an estimated $12K and bringing the position to 1,317 shares worth $9.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3908.

Tower Research Capital (TRC) first reported a position in EXOZ in Q4 2024 and has held it in 5 quarters since. The position peaked at $11.8K in Q1 2025. 7 funds tracked by Wall St. Rank hold EXOZ as of Q1 2026.

  • Tower Research Capital (TRC) held 1,317 shares of eXoZymes Inc worth $9.89K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,315 eXoZymes Inc shares in Q1 2026, an estimated $12K.
  • eXoZymes Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3908 holding.
  • Tower Research Capital (TRC) first reported a position in eXoZymes Inc in Q4 2024 and has held it in 5 quarters since.
  • Tower Research Capital (TRC)'s eXoZymes Inc position peaked at $11.8K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held eXoZymes Inc as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.